358 related articles for article (PubMed ID: 21984960)
1. Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeutics.
Chittasupho C; Siahaan TJ; Vines CM; Berkland C
Ther Deliv; 2011 Jul; 2(7):873-89. PubMed ID: 21984960
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic blockade of T-cell antigen receptor signal transduction and costimulation in autoimmune disease.
Podojil JR; Turley DM; Miller SD
Adv Exp Med Biol; 2008; 640():234-51. PubMed ID: 19065796
[TBL] [Abstract][Full Text] [Related]
3. The role of AhR in autoimmune regulation and its potential as a therapeutic target against CD4 T cell mediated inflammatory disorder.
Zhu C; Xie Q; Zhao B
Int J Mol Sci; 2014 Jun; 15(6):10116-35. PubMed ID: 24905409
[TBL] [Abstract][Full Text] [Related]
4. Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases.
Moral MEG; Siahaan TJ
Curr Top Med Chem; 2017; 17(32):3425-3443. PubMed ID: 29357802
[TBL] [Abstract][Full Text] [Related]
5. PKC-θ function at the immunological synapse: prospects for therapeutic targeting.
Zanin-Zhorov A; Dustin ML; Blazar BR
Trends Immunol; 2011 Aug; 32(8):358-63. PubMed ID: 21733754
[TBL] [Abstract][Full Text] [Related]
6. Boosting interleukin-10 production: therapeutic effects and mechanisms.
Zhou X; Schmidtke P; Zepp F; Meyer CU
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Dec; 5(4):465-75. PubMed ID: 16375698
[TBL] [Abstract][Full Text] [Related]
7. Targeting T cell costimulation in autoimmune disease.
Stuart RW; Racke MK
Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
[TBL] [Abstract][Full Text] [Related]
8. Upholding the T cell immune-regulatory function of CD31 inhibits the formation of T/B immunological synapses in vitro and attenuates the development of experimental autoimmune arthritis in vivo.
Clement M; Fornasa G; Loyau S; Morvan M; Andreata F; Guedj K; Khallou-Laschet J; Larghi P; Le Roux D; Bismuth G; Chiocchia G; Hivroz C; Newman DK; Nicoletti A; Caligiuri G
J Autoimmun; 2015 Jan; 56():23-33. PubMed ID: 25277651
[TBL] [Abstract][Full Text] [Related]
9. Therapies Targeting Trained Immune Cells in Inflammatory and Autoimmune Diseases.
Municio C; Criado G
Front Immunol; 2020; 11():631743. PubMed ID: 33569065
[TBL] [Abstract][Full Text] [Related]
10. Emerging peptide therapeutics for inflammatory autoimmune diseases.
Briand JP; Muller S
Curr Pharm Des; 2010; 16(9):1136-42. PubMed ID: 20030611
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte adhesion and autoimmunity.
Tapia M; Mor A
Bull Hosp Jt Dis (2013); 2014; 72(2):148-53. PubMed ID: 25150342
[TBL] [Abstract][Full Text] [Related]
12. An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease.
Comerford I; Bunting M; Fenix K; Haylock-Jacobs S; Litchfield W; Harata-Lee Y; Turvey M; Brazzatti J; Gregor C; Nguyen P; Kara E; McColl SR
Bioessays; 2010 Dec; 32(12):1067-76. PubMed ID: 20954179
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Immunogenicity of Proteins Used as Therapeutics.
Sauna ZE; Richards SM; Maillere B; Jury EC; Rosenberg AS
Front Immunol; 2020; 11():614856. PubMed ID: 33193460
[No Abstract] [Full Text] [Related]
14. Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.
Gonzalez-Rey E; Anderson P; Delgado M
Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii70-6. PubMed ID: 17934101
[TBL] [Abstract][Full Text] [Related]
15. Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis.
Lai JH; Luo SF; Ho LJ
Cells; 2019 Aug; 8(8):. PubMed ID: 31426619
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte Activation in Health and Disease.
Berridge MJ
Crit Rev Immunol; 2017; 37(2-6):439-462. PubMed ID: 29773029
[TBL] [Abstract][Full Text] [Related]
17. Selective CD28 Antagonist Blunts Memory Immune Responses and Promotes Long-Term Control of Skin Inflammation in Nonhuman Primates.
Poirier N; Chevalier M; Mary C; Hervouet J; Minault D; Baker P; Ville S; Le Bas-Bernardet S; Dilek N; Belarif L; Cassagnau E; Scobie L; Blancho G; Vanhove B
J Immunol; 2016 Jan; 196(1):274-83. PubMed ID: 26597009
[TBL] [Abstract][Full Text] [Related]
18. [Regulation of Toll-like receptors-dependent inflammatory response].
Kowalczyk E; Siednienko J; Matuszyk J
Postepy Hig Med Dosw (Online); 2013 Mar; 67():201-13. PubMed ID: 23619219
[TBL] [Abstract][Full Text] [Related]
19. Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse.
Choudhuri K; Llodrá J; Roth EW; Tsai J; Gordo S; Wucherpfennig KW; Kam LC; Stokes DL; Dustin ML
Nature; 2014 Mar; 507(7490):118-23. PubMed ID: 24487619
[TBL] [Abstract][Full Text] [Related]
20. Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools.
Ben Mkaddem S; Benhamou M; Monteiro RC
Front Immunol; 2019; 10():811. PubMed ID: 31057544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
